Phio Pharmaceuticals Corp. Soared
Fri, May 07, 2021 at 05:33 PM
Phio Pharmaceuticals Corp. (PHIO:NASDAQ) rocketted at $2.67, representing a gain of 21.9%. On Thu, May 06, 2021, PHIO:NASDAQ touched a New 2-Week Low of $2.19. The stock got featured on our News Catalysts scanner on Thu, Apr 29, 2021 at 08:38 AM in the 'MISCELLANEOUS' category. From Thu, Apr 22, 2021, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Thu, Feb 18, 2021 at $4.36 with a volume of 4M+, and its share price has been moving sideways in recent weeks.
About Phio Pharmaceuticals Corp. (PHIO:NASDAQ)
RXi Pharmaceuticals Corp is principally engaged in developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs.
Top 10 Gainers:
- Velocity Financial, Inc. (VEL:NYSE), 36.61%
- Yield10 Bioscience, Inc. (YTEN:NASDAQ), 26.22%
- The L.S. Starrett Company (SCX:NYSE), 26.21%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 24.17%
- Core Molding Technologies, Inc. (CMT:NYSEMKT), 23.5%
- MoneyGram International, Inc. (MGI:NASDAQ), 22.78%
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 21.92%
- Cooper-Standard Holdings Inc. (CPS:NYSE), 21.92%
- Epizyme, Inc. (EPZM:NASDAQ), 21.73%
- MEDNAX, Inc. (MD:NYSE), 19.96%